Clinical Trial: Desvenlafaxine Monotherapy in Dysthymia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An 8-week Open-Label Flexible-Dose Study Of Desvenlafaxine as Monotherapy In The Treatment Of Dysthymia

Brief Summary: This multi-centred study will be conducted at two centres. The design will be an open label, flexible-dose study. This investigation will evaluate the efficacy of Desvenlafaxine monotherapy for patients who meet diagnostic criteria for dysthymia.